Search results for "Androgen"

showing 10 items of 326 documents

Sex hormones and risk of liver tumor.

2007

The liver is morphologically and functionally modulated by sex hormones. Long-term use of oral contraceptives (OCs) and anabolic androgenic steroids (AASs) can induce both benign (hemangioma, adenoma, and focal nodular hyperplasia [FNH]) and malignant (hepatocellular carcinoma [HCC]) hepatocellular tumors. Hepatic adenomas (HAs) are rare, benign neoplasms usually occurring in young women, the development and the complications of which have been related to the strength of OCs and the duration of their use. HA incidence has fallen since the introduction of pills containing smaller amounts of estrogens. FNH is a benign lesion, most commonly seen in young women, which is thought to represent a …

MaleRiskmedicine.medical_specialtyCirrhosisLiver tumorAdenomamedicine.drug_classPhysiologyBiologyGeneral Biochemistry Genetics and Molecular BiologyAndrogenAromataseHistory and Philosophy of ScienceInternal medicinemedicineHumansSex RatioHCCGonadal Steroid HormonesHepatitisGeneral NeuroscienceLiver NeoplasmsFocal nodular hyperplasiaCancermedicine.diseaseEstrogenEndocrinologyLiverReceptors EstrogenEstrogenReceptors AndrogenHepatocellular carcinomaFemaleBenign liver tumorAnnals of the New York Academy of Sciences
researchProduct

Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines.

2009

International audience; Glyphosate-based herbicides are the most widely used across the world; they are commercialized in different formulations. Their residues are frequent pollutants in the environment. In addition, these herbicides are spread on most eaten transgenic plants, modified to tolerate high levels of these compounds in their cells. Up to 400 ppm of their residues are accepted in some feed. We exposed human liver HepG2 cells, a well-known model to study xenobiotic toxicity, to four different formulations and to glyphosate, which is usually tested alone in chronic in vivo regulatory studies. We measured cytotoxicity with three assays (Alamar Blue (R), MTT ToxiLight (R)), plus gen…

MaleTranscription GeneticEstrogen receptor010501 environmental sciencesEndocrine DisruptorsToxicologymedicine.disease_cause01 natural scienceschemistry.chemical_compoundGenes ReporterAromataseCytotoxicityendocrine disruptor0303 health sciencesroundupsexual steroidsEndocrine disruptorBiochemistryReceptors AndrogenComet Assaymedicine.medical_specialtyHepG2AdolescentGlycine[SDV.TOX.TCA]Life Sciences [q-bio]/Toxicology/Toxicology and food chainBiology03 medical and health sciencesAromataseglyphosateInternal medicineCell Line TumorToxicity TestsmedicineEstrogen Receptor betaHumansRNA MessengerCarcinogen030304 developmental biology0105 earth and related environmental sciencesDose-Response Relationship DrugHerbicidesEstrogen Receptor alphaPesticide ResiduesComet assayEndocrinologychemistry13. Climate actionbiology.proteinXenobioticGenotoxicityDNA DamageToxicology
researchProduct

AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC

2019

<b><i>Introduction:</i></b> Androgen receptor variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC) and has shown potential as a predictive biomarker in circulating tumour cells (CTCs) isolated from the bloodstream in terms of a liquid biopsy. Studies have shown that AR-V7 is a potential surrogate for selecting drug classes for systemic treatment by detecting nuclear AR-V7 by immunofluorescence or measuring AR-V7 messenger RNA by quantitative PCR. Here, we assessed the predictive value of AR-V7 detected by classical immunohistochemistry (IHC) for treatment response. <b><i>Methods:</i></b> C…

MaleUrology030232 urology & nephrologyAntineoplastic AgentsDocetaxel03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicineCell Line TumormedicineHumansEnzalutamideProspective StudiesLiquid biopsyAgedAged 80 and overbusiness.industryAndrogen AntagonistsNeoplastic Cells CirculatingPrognosismedicine.diseaseAndrogen receptorProstatic Neoplasms Castration-ResistantTreatment OutcomeDocetaxelchemistryReceptors AndrogenCabazitaxel030220 oncology & carcinogenesisCancer researchBiomarker (medicine)ImmunohistochemistryTaxoidsbusinessmedicine.drugUrologia Internationalis
researchProduct

Immunomodulatory Mechanisms Mediated by Sex Hormones in Rheumatoid Arthritis

1996

Malebusiness.industryGeneral Neurosciencemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyArthritis RheumatoidReceptors EstrogenHistory and Philosophy of ScienceReceptors AndrogenRheumatoid arthritisImmunologyHumansMedicineFemaleGonadal Steroid HormonesbusinessHormoneAnnals of the New York Academy of Sciences
researchProduct

Biochemical selection of prepubertal patients with androgen insensitivity syndrome by sex hormone-binding globulin response to the human chorionic go…

1997

Before puberty, the diagnosis of androgen insensitivity syndrome (AIS) can be difficult. We studied whether the decrease of sex hormone-binding globulin (SHBG) during the human chorionic gonadotropin (hCG) test may represent a biochemical test to select prepubertal patients with AIS. We examined prepubertal patients with AIS (n = 9, age 0.9-8.2 y), male pseudohermaphroditism not due to AIS (other-MPH) (n = 8, age 0.6-10.7 y), and control boys (n = 12, age 0.8-12.5 y). Testosterone and SHBG levels (mean +/- SD) were measured before (d 0) and after (d 5) a hCG test (1500 IU X 3 d). Testosterone levels (nmol/L) increased in all groups [AIS: from 1.5 +/- 1.2 to 22.1 +/- 11.8 (p0.001); other-MPH…

Maleendocrine systemmedicine.medical_specialtyGlobulinmedicine.drug_classDisorders of Sex DevelopmentEndocrine System DiseasesChorionic GonadotropinHuman chorionic gonadotropinSex hormone-binding globulinInternal medicineSex Hormone-Binding GlobulinmedicineHumansTestosteroneChildSelection (genetic algorithm)biologyurogenital systemPatient SelectionInfantSyndromeAndrogenmedicine.diseaseEndocrinologyReceptors AndrogenCase-Control StudiesChild PreschoolKaryotypingembryonic structuresPediatrics Perinatology and Child Healthbiology.proteinAndrogensAndrogen insensitivity syndromeGonadotropinSex Hormone Binding ProteinPediatric research
researchProduct

Inhibin-α, CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome

2000

We investigated 115 testicular and 3 epididymal tumors and 6 cases of the complete androgen insensitivity syndrome (AIS) for the expression of inhibin-alpha, CD99, HEA125, PLAP, and chromogranin, using monoclonal antibodies and standard immunhistochemical techniques. Ihibin-alpha was detected in the neoplastic cells in 27 of 27 primary Leydig cell tumors (LCTs), 1 of 1 metastatic LCT, 6 of 20 Sertoli cell tumors (SCTs), 4 of 5 juvenile granulosa cell tumors (GCTs), and 2 of 5 unclassified sex cord-stromal tumors (USCSTs). Except for 2 choriocarcinomas, the choriocarcinomatous component of 1 mixed germ cell tumor, and a small focus of inhibin-positive syncytiotrophoblast in 1 embryonal carci…

Maleendocrine systemmedicine.medical_specialtyPathologyendocrine system diseasesCD9912E7 AntigenBiologyPathology and Forensic MedicineEmbryonal carcinomaTesticular NeoplasmsAntigens CDAntigens NeoplasmRete testisInternal medicineBiomarkers TumorChromograninsmedicineHumansInhibinsRhabdomyosarcomaGranulosa Cell TumorEpididymisLeydig cellProteinsChromogranin AAndrogen-Insensitivity Syndromemedicine.diseaseSertoli cellNeoplasm Proteinsmedicine.anatomical_structureEndocrinologyFluorescent Antibody Technique DirectAntigens Surfacebiology.proteinGerm cell tumorsPeptidesCell Adhesion MoleculesHuman Pathology
researchProduct

Testosterone metabolism in patients with advanced carcinoma of the prostate: a comparative in vivo study of the effects of oestrogen and antiprolacti…

1978

In the light of the high incidence of cardiovascular side effects with oestrogen therapy in patients with prostatic cancer, other medications altering androgen metabolism are under investigation. The influence of the anti-prolactin bromocriptine (CB154) on plasma kinetics of testosterone and on endogenous hormones was studied and compared with the effect of ethinyl oestradiol in 25 patients with prostatic carcinoma. Bromocriptine significantly suppressed both prolactin and testosterone, inhibited the transfer of androgen from the inner pool into the deep compartment and favoured its degradation. Ethinyl oestradiol decreased testosterone, LH and FSH, and prolonged the biological half-life of…

Maleendocrine systemmedicine.medical_specialtymedicine.drug_classUrologyProstateInternal medicinemedicineCarcinomaHumansTestosteroneTestosteroneBromocriptineDose-Response Relationship DrugEstradiolbusiness.industryCancerProstatic NeoplasmsLuteinizing HormoneAndrogenmedicine.diseaseProlactinBromocriptineProlactinmedicine.anatomical_structureEndocrinologyReceptors AndrogenFollicle Stimulating Hormonebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugHormoneUrological research
researchProduct

17beta-hydroxysteroid dehydrogenase-3 deficiency: a rare endocrine cause of male-to-female sex reversal.

2006

Deficiency of 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3), due to mutations in the gene encoding the enzyme, results in a rare autosomal recessive form of male-to-female sex reversal. Mutated genes encode an abnormal enzyme with absent or reduced ability to convert Delta4-androstenedione to testosterone in the testis. Affected individuals are genetically males who developed internal male Wolffian structures but female external genitalia. Such individuals are usually raised as females and diagnosis is made at puberty, when they show virilization. Correct diagnosis is mandatory to optimize treatment and follow-up. In the present paper we report the clinical history, endocrine eva…

Malemedicine.medical_specialty17-Hydroxysteroid DehydrogenasesEndocrinology Diabetes and MetabolismDisorders of Sex Development17beta-hydroxysteroid dehydrogenaseBiologyEndocrine System Diseaseschemistry.chemical_compoundEndocrinologyMolecular geneticsInternal medicinemedicineEndocrine systemHumansGeneTestosteroneVirilizationObstetrics and GynecologySex reversalmedicine.diseaseEndocrinologychemistryChild PreschoolAndrogensAndrogen insensitivity syndromeFemalemedicine.symptomGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

Decreased prevalence of left-handedness among females with male co-twins: evidence suggesting prenatal testosterone transfer in humans?

2009

Studies of singletons suggest that right-handed individuals may have higher levels of testosterone than do left-handed individuals. Prenatal testosterone levels are hypothesised to be especially related to handedness formation. In humans, female members from opposite-sex twin pairs may experience elevated level of prenatal exposure to testosterone in their intra-uterine environment shared with a male. We tested for differences in rates of left-handedness/right-handedness in female twins from same-sex and opposite-sex twin pairs. Our sample consisted of 4736 subjects, about 70% of all Finnish twins born in 1983–1987, with information on measured pregnancy and birth related factors. Circulati…

Malemedicine.medical_specialtyAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismBirth weightPopulationGestational Age050105 experimental psychologyFunctional LateralityArticle03 medical and health sciences0302 clinical medicineEndocrinology5. Gender equalityPregnancyInternal medicinemedicineTwins DizygoticBirth WeightHumans0501 psychology and cognitive sciencesTestosteroneeducationSalivaMaternal-Fetal ExchangeBiological PsychiatryFinlandPrenatal testosterone transferPregnancyeducation.field_of_studySex CharacteristicsEstradiolEndocrine and Autonomic Systems05 social sciencesInfant NewbornTestosterone (patch)medicine.diseaseAndrogenTwin studyPsychiatry and Mental healthEndocrinologyApgar ScoreFemalePsychology030217 neurology & neurosurgerySex characteristicsMaternal AgePsychoneuroendocrinology
researchProduct

Studies on the Effects of the Antiandrogen Cyproterone Acetate on Social Encounters Between Pairs of Male Mice

1988

An attempt was made in two experiments to reinvestigate the effects of the antiandrogen cyproterone acetate (CA) on mouse social behavior in a variety of ethologically-assessed paired encounters. The data confirm that CA reduces offense (threat and attack) in animals when both subjects receive the material but that CA has no such action in other pairings. This suggests that CA's major suppressive effect on "hostility" is expressed in mice via a reduction in "attack-promoting" pheromone production. Indeed, there was evidence in the more chronic study that CA, could augment (via a central mechanism?) offense in subjects paired with docile anosmic opponents. Changes in defense were largely res…

Malemedicine.medical_specialtyAntiandrogensmedicine.drug_classMale miceHostilityAntiandrogenMicechemistry.chemical_compoundInternal medicinemedicineAnimalsCyproteroneCyproterone AcetateBehavior AnimalDose-Response Relationship DrugAggressionGeneral NeuroscienceCyproterone acetateAndrogen AntagonistsGeneral MedicineEndocrinologychemistryCyproteronePheromonemedicine.symptomPsychologymedicine.drugInternational Journal of Neuroscience
researchProduct